Pfizer recently purchased rival Arena Pharmaceuticals for $6.7 billion and as a result will now control drug products that treat immuno-inflammatory diseases. It is of course merely a coincidence that various immuno-inflammatory diseases are associated with vaccine injury. But if it’s not a coincidence, that means Pfizer will be profiting by treating people injured by the company’s own vaccine. Jimmy Dore reports.
https://www.youtube.com/watch?v=Cak9vo9ptR4